Literature DB >> 2191947

N-acetylcolchinol O-methyl ether and thiocolchicine, potent analogs of colchicine modified in the C ring. Evaluation of the mechanistic basis for their enhanced biological properties.

G J Kang1, Z Getahun, A Muzaffar, A Brossi, E Hamel.   

Abstract

Two colchicine analogs with modifications only in the C ring are better inhibitors than colchicine of cell growth and tubulin polymerization. Radiolabeled thiocolchicine (with a thiomethyl instead of a methoxy group at position C-10) and N-acetylcolchinol O-methyl ether (NCME) (with a methoxy-substituted benzenoid instead of the methoxy-substituted tropone C ring) were prepared for comparison with colchicine. Scatchard analysis indicated a single binding site with KD values of 1.0-2.3 microM. Thiocolchicine was bound 2-4 times as rapidly as colchicine, but the activation energies of the reactions were nearly identical (18 kcal/mol for colchicine, 20 kcal/mol for thiocolchicine). NCME bound to tubulin in a biphasic reaction. The faster phase was 60 times as fast as colchicine binding at 37 degrees C, and a substantial reaction occurred at 0 degrees C. The rate of the faster phase of NCME binding changed relatively little as a function of temperature, so the activation energy was only 7.0 kcal/mol. Dissociation reactions were also evaluated, and at 37 degrees C the half-lives of the tubulin-drug complexes were 11 min for NCME, 24 h for thiocolchicine, and 27 h for colchicine. Relative dissociation rates as a function of temperature varied little among the drug complexes. Activation energies for the dissociation reactions were 30 kcal/mol for thiocolchicine, 27 kcal/mol for NCME, and 24 kcal/mol for colchicine. Comparison of the activation energies of association and dissociation yielded free energies for the binding reactions of -20 kcal/mol for NCME, -10 kcal/mol for thiocolchicine, and -6 kcal/mol for colchicine. The greater effectiveness of NCME and thiocolchicine as compared with colchicine in biological assays probably derives from their more rapid binding to tubulin and the lower free energies of their binding reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191947

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Interaction of pseudolaric acid B with the colchicine site of tubulin.

Authors:  Taradas Sarkar; Tam Luong Nguyen; Zhi-Wei Su; Jun Hao; Ruoli Bai; Rick Gussio; Samuel X Qiu; Ernest Hamel
Journal:  Biochem Pharmacol       Date:  2012-05-23       Impact factor: 5.858

2.  ELR510444, a novel microtubule disruptor with multiple mechanisms of action.

Authors:  A L Risinger; C D Westbrook; A Encinas; M Mülbaier; C M Schultes; S Wawro; J D Lewis; B Janssen; F J Giles; S L Mooberry
Journal:  J Pharmacol Exp Ther       Date:  2010-12-09       Impact factor: 4.030

3.  Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

Authors:  Bernard L Flynn; Gurmit S Gill; Damian W Grobelny; Jason H Chaplin; Dharam Paul; Annabell F Leske; Tina C Lavranos; David K Chalmers; Susan A Charman; Edmund Kostewicz; David M Shackleford; Julia Morizzi; Ernest Hamel; M Katherine Jung; Gabriel Kremmidiotis
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

4.  A screen for kinetochore-microtubule interaction inhibitors identifies novel antitubulin compounds.

Authors:  Emanuela Screpanti; Stefano Santaguida; Tam Nguyen; Romano Silvestri; Rick Gussio; Andrea Musacchio; Ernest Hamel; Peter De Wulf
Journal:  PLoS One       Date:  2010-07-15       Impact factor: 3.240

5.  Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.

Authors:  Elena Porcù; Attila Sipos; Giuseppe Basso; Ernest Hamel; Ruoli Bai; Verena Stempfer; Antal Udvardy; Attila Cs Bényei; Helmut Schmidhammer; Sándor Antus; Giampietro Viola
Journal:  Eur J Med Chem       Date:  2014-07-16       Impact factor: 6.514

6.  Evading Pgp activity in drug-resistant cancer cells: a structural and functional study of antitubulin furan metotica compounds.

Authors:  Tam Luong Nguyen; Maria Rosaria Cera; Andrea Pinto; Leonardo Lo Presti; Ernest Hamel; Paola Conti; Rick Gussio; Peter De Wulf
Journal:  Mol Cancer Ther       Date:  2012-03-21       Impact factor: 6.261

7.  Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide.

Authors:  Kelsey E Knewtson; Chamani Perera; David Hymel; Zhe Gao; Molly M Lee; Blake R Peterson
Journal:  ACS Omega       Date:  2019-07-31

Review 8.  Mitotic Poisons in Research and Medicine.

Authors:  Jan Škubník; Michal Jurášek; Tomáš Ruml; Silvie Rimpelová
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.